Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-05T04:23:56.122Z Has data issue: false hasContentIssue false

A screening strategy for latent tuberculosis in healthcare workers: Cost-effectiveness and budget impact of universal versus targeted screening

Published online by Cambridge University Press:  21 February 2019

May Ee Png
Affiliation:
Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore
Joanne Yoong*
Affiliation:
Center for Economic and Social Research East, University of Southern California, Washington, DC, United States
Catherine Wei Min Ong
Affiliation:
Division of Infectious Disease, Department of Medicine, National University Health System, Singapore, Singapore Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Dale Fisher
Affiliation:
Division of Infectious Disease, Department of Medicine, National University Health System, Singapore, Singapore Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
Natasha Bagdasarian
Affiliation:
Division of Infectious Disease, Department of Medicine, National University Health System, Singapore, Singapore Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
*
Author for correspondence: Joanne Yoong, Email: [email protected]

Abstract

Objective:

To evaluate the clinical, cost-efficiency, and budgetary implications of universal versus targeted latent tuberculosis infection (LTBI) screening strategies among healthcare workers (HCWs) in an intermediate tuberculosis (TB)-burden country.

Design:

Pragmatic cost-effectiveness and budget impact analysis using decision-analytic modeling.

Setting:

A tertiary-care hospital in Singapore.

Methods:

We compared 7 potentially implementable LTBI screening programs including universal and targeted strategies with different screening frequencies. Feasible targeting methods included stratification by country of origin (a proxy for risk of prior TB exposure) and by high-risk occupation. The clinical and financial consequences of each strategy were estimated relative to “no screening” (current practice) and compared to locally appropriate cost-effectiveness thresholds. All analyses were conducted from the hospital’s perspective over a 3-year time horizon, based on the typical hospital planning period. Parameter uncertainties were accounted for using sensitivity analyses.

Results:

In our model, relative to current practice, screening new international hires and triennial screening of existing high-risk workers is most cost-effective (US$58 per quality adjusted life year [QALY]) and decreases active TB cases from 19 to 14. Screening all new hires combined with triennial universal screening, with or without annual high-risk screening or annual universal screening, reduced active TB to a range of 19 to 6 cases, but these strategies are less cost-effective and require substantially higher expenditures.

Conclusions:

Targeted LTBI screening for HCWs can be highly cost-effective for hospitals in settings similar to Singapore. More inclusive screening strategies (including regular universal screening) can yield better outcomes but are less efficient and may even be unaffordable.

Type
Original Article
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Menzies, D, Fanning, A, Yuan, L, Fitzgerald, M. Tuberculosis among health care workers. N Engl J Med 1995;332:9298.CrossRefGoogle ScholarPubMed
Davidson, JA, Lalor, MK, Anderson, LF, Tamne, S, Abubakar, I, Thomas, HL. TB in healthcare workers in the UK: a cohort analysis 2009–2013. Thorax 2017;72:654659.CrossRefGoogle ScholarPubMed
Sydnor, ERM, Perl, TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 2011;24:141173.CrossRefGoogle ScholarPubMed
Martin Williams, O, Abeel, T, Casali, N, et al. Fatal nosocomial MDR TB identified through routine genetic analysis and whole-genome sequencing. Emerg Infect Dis 2015;21:10821084.CrossRefGoogle Scholar
Schluger, NW. The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years. Am J Respir Cell Mol Biol 2005;32:251256.CrossRefGoogle ScholarPubMed
Lambert, LA, Pratt, RH, Armstrong, LR, Haddad, MB. Tuberculosis among healthcare workers, United States, 1995–2007. Infect Control Hosp Epidemiol 2012;33:11261132.CrossRefGoogle ScholarPubMed
Jensen, PA, Lambert, LA, Iademarco, MF. Guidelines for Preventing the Transmission of Mycobacterium Tuberculosis in Health-Care Settings. Atlanta, GA: CDC; 2005.Google ScholarPubMed
Tuberculosis. Singapore Ministry of Health website. https://www.moh.gov.sg/content/moh_web/home/diseases_and_conditions/t/tuberculosis.html. Published 2017. Accessed October 1, 2017.Google Scholar
Demographics of nursing professionals in Singapore. Singapore Ministry of Health website. https://www.moh.gov.sg/content/moh_web/home/pressRoom/Parliamentary_QA/2012/demographics_of_nursingprofessionalsinsingapore.html. Published 2012. Accessed October 1, 2017.Google Scholar
Global HIV and Tuberculosis. Centers for Disease Control and Prevention website. https://www.cdc.gov/globalhivtb/where-we-work/philippines/philippines.html. Published 2016. Accessed June 1, 2017.Google Scholar
Chee, CBE, Wang, YT. TB control in Singapore: Where do we go from here? Singapore Med J 2012;53:236238.Google Scholar
Bagdasarian, N, Chan, H, Ang, S, Isa, M, Chan, S, Fisher, D. A“ Stone in the pond” approach to contact tracing: responding to a large-scale, nosocomial tuberculosis exposure in a moderate TB-burden setting. Infect Control Hosp Epidemiol 2017;38:13.CrossRefGoogle Scholar
Casas, I, Esteve, M, Guerola, R, et al. Incidence of tuberculosis infection among healthcare workers: risk factors and 20-year evolution. Respir Med 2013;107:601607.CrossRefGoogle ScholarPubMed
Baussano, I, Bugiani, M, Carosso, A, et al. Risk of tuberculin conversion among healthcare workers and the adoption of preventive measures. Occup Environ Med 2007;64:161166.CrossRefGoogle ScholarPubMed
Cook, S, Maw, KL, Munsiff, SS, Fujiwara, PI, Frieden, TR. Prevalence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001. Infect Control Hosp Epidemiol 2003;24:807813.CrossRefGoogle ScholarPubMed
Kowada, A, Takasaki, J, Kobayashi, N. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries. J Hosp Infect 2015;89:99108.CrossRefGoogle ScholarPubMed
Exchange rates. Monetary Authority of Singapore website. https://secure.mas.gov.sg/msb/ExchangeRates.aspx. Published 2016. Accessed June 1, 2017.Google Scholar
Grosse, SD. Assessing cost-effectiveness in healthcare: history of the $50, 000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 2008;8:165178.CrossRefGoogle ScholarPubMed
Sullivan, SD, Mauskopf, JA, Augustovski, F, et al. Budget impact analysis principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Heal 2014;17:514.CrossRefGoogle ScholarPubMed
Menzies, D, Joshi, R, Pai, M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007;11:593605.Google ScholarPubMed
Salpeter, SR, Salpeter, EE. Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis. Infect Control Hosp Epidemiol 2004;25:10561061.CrossRefGoogle ScholarPubMed
World Health Organization. Global tuberculosis report 2016. http://www.who.int/tb/publications/global_report/en/. Published 2017. Accessed April 1, 2017.Google Scholar
del Campo, MT, Fouad, H, Solis-Bravo, MM, Sanchez-Uriz, MA, Mahillo-Fernandez, I, Esteban, J. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers. Infect Control Hosp Epidemiol 2012;33:12261234.CrossRefGoogle Scholar
Pathak, V, Harrington, Z, Dobler, CC. Attitudes towards preventive tuberculosis treatment among hospital staff. PeerJ 2016;4:e1738.CrossRefGoogle ScholarPubMed
Dobler, ACC, Martin, A, Marks, GB, et al. Benefit of treatment of latent tuberculosis infection in individual patients. Eur Respir J 2015;46:13971406.CrossRefGoogle ScholarPubMed
Singer, ME. Advanced sensitivity analyses: probabilistic, correlated and scenario. Veterans Affairs Health Services and Research and Development website. http://www.hsrd.research.va.gov/for_researchers/cyber_seminars/archives/Slides_Singer.ppt. Published 2006. Accessed April 1, 2017.Google Scholar
Mullie, GA, Schwartzman, K, Zwerling, A, N’Diaye, DS. Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis. BMC Med 2017;15:104.CrossRefGoogle ScholarPubMed
Teichert, E. Tenet Healthcare sued for $1.5 billion over tuberculosis exposure. Modern Healthcare website. http://www.modernhealthcare.com/article/20161108/NEWS/161109926. Published 2016. Accessed April 1, 2017.Google Scholar
Walker, TM, Ip, CLC, Harrell, RH, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: A retrospective observational study. Lancet Infect Dis 2013;13:137146.CrossRefGoogle ScholarPubMed
Eralp, MN, Scholtes, S, Martell, G, Winter, R, Exley, AR. Screening of healthcare workers for tuberculosis: development and validation of a new health economic model to inform practice. BMJ Open 2012;2:e000630.CrossRefGoogle ScholarPubMed
Zwerling, A, van den Hof, S, Scholten, J, Cobelens, F, Menzies, D, Pai, M. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax 2012;67:6270.CrossRefGoogle ScholarPubMed
Saukkonen, JJ, Cohn, DL, Jasmer, RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006;174:935952.CrossRefGoogle ScholarPubMed
Supplementary material: File

Png et al. supplementary material

Png et al. supplementary material 1

Download Png et al. supplementary material(File)
File 13.8 KB